Lam Research Corp header image

Lam Research Corp

LRCX

Equity

ISIN null / Valor 138658329

NASDAQ (2026-03-30)
USD 199.93-5.43%

Lam Research Corp
UMushroom community rating:

star star star star star
4.23 3 votes No rating yet
NegativeNeutralPositive

About company

Lam Research Corporation is a prominent player in the semiconductor industry, specializing in the design and manufacture of equipment used in the fabrication of integrated circuits. The company is renowned for its advanced etch and deposition solutions, which are critical processes in the production of semiconductor devices. Lam Research's product portfolio is essential for enabling the miniaturization and performance enhancement of electronic components, which are foundational to modern technology. The company operates on a global scale, with a focus on innovation and efficiency to support the semiconductor manufacturing sector. With a strong leadership team, Lam Research continues to drive technological advancements and operational excellence, ensuring its position as a key supplier to semiconductor manufacturers worldwide.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

175%1Y
276%3Y
249%5Y

Performance

52.3%1Y
44.9%3Y
45.3%5Y

Volatility

Market cap

249667 M

Market cap (USD)

Daily traded volume (Shares)

11,921,042

Daily traded volume (Shares)

1 day high/low

72.59 / 71.27

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.23

3 votes
Performance:
starstarstarstarstar
4.23
Innovation:
starstarstarstarstar
4.23
Society:
starstarstarstarstar
4.23
Nature:
starstarstarstarstar
3.77
Benjamin Gan Cheng Ng
United Kingdom, 21 Feb 2026
star star star star star
Great
Benjamin Gan Cheng Ng
United Kingdom, 20 Feb 2026
star star star star star
Good
Jimi Rai
United Kingdom, 06 Nov 2025
star star star star star
Over 110% one-year return, consistently surpassing EPS estimates. Semiconductors are crucial for the future, and Lam Research is going to be a key player.

EQUITIES OF THE SAME SECTOR

Ansys Inc
Ansys Inc Ansys Inc Valor: 492019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 374.30
Verisign Inc
Verisign Inc Verisign Inc Valor: 847364
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.88%USD 249.67
The Trade Desk Inc
The Trade Desk Inc The Trade Desk Inc Valor: 33717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.43%USD 22.01
CrowdStrike Holdings Inc
CrowdStrike Holdings Inc CrowdStrike Holdings Inc Valor: 47976949
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.84%USD 380.06
Datadog Inc
Datadog Inc Datadog Inc Valor: 49718937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 115.81
Biomarin Pharmaceutical Inc
Biomarin Pharmaceutical Inc Biomarin Pharmaceutical Inc Valor: 729021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.20%USD 54.79
Take-Two Interactive Software Inc
Take-Two Interactive Software Inc Take-Two Interactive Software Inc Valor: 622906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.79%USD 193.08
Check Point Software Technologies Ltd
Check Point Software Technologies Ltd Check Point Software Technologies Ltd Valor: 494683
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.70%USD 141.20
Amkor Technology Inc
Amkor Technology Inc Amkor Technology Inc Valor: 867805
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.20%USD 41.25
Ascendis Pharma
Ascendis Pharma Ascendis Pharma Valor: 26912602
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.65%USD 218.35